We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$91.3B
AUM Growth
+$2.98B
(+3.4%)
Cap. Flow
-$825M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
34.96%
Holding
259
New
7
Increased
73
Reduced
140
Closed
5
Avg Time Held
0.9
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$144M |
| 2 |
Jacobs Solutions
J
|
+$83.6M |
| 3 |
CSX Corp
CSX
|
+$52.1M |
| 4 |
Ross Stores
ROST
|
+$51.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$218M |
| 2 |
Electronic Arts
EA
|
+$134M |
| 3 |
FedEx
FDX
|
+$124M |
| 4 |
Medtronic
MDT
|
+$120M |
| 5 |
Visa
V
|
+$83.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.36% |
| 2 | Healthcare | 25.97% |
| 3 | Industrials | 13.99% |
| 4 | Miscellaneous | 7.28% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
CME Group
CME
$104B
| $264M | 0.29% |
3,724,250
-206,507
| -5% | -$14.5M |
2013 Q2
4 quarters
|
|
|
BBBY
77
DELISTED
Bed Bath & Beyond Inc
BBBY
| $258M | 0.28% |
4,497,756
-38,000
| -0.8% | -$2.37M |
2013 Q2
4 quarters
|
|
78
Ericsson
ERIC
$34.8B
| $254M | 0.28% |
21,010,814
+2,051,600
| +11% | +$25.5M |
2013 Q2
4 quarters
|
|
79
CVS Health
CVS
$118B
| $242M | 0.26% |
3,206,070
-15,860
| -0.5% | -$1.2M |
2013 Q2
4 quarters
|
|
80
JetBlue
JBLU
$1.19B
| $240M | 0.26% |
22,128,539
-675,450
| -3% | -$6.24M |
2013 Q2
4 quarters
|
|
81
Analog Devices
ADI
$196B
| $239M | 0.26% |
4,416,485
+12,550
| +0.3% | +$664K |
2013 Q2
4 quarters
|
|
|
POLY
82
DELISTED
Plantronics, Inc.
POLY
| $236M | 0.26% |
4,910,950
| – | – |
2013 Q2
4 quarters
|
|
83
Accenture
ACN
$138B
| $226M | 0.25% |
2,801,050
-6,700
| -0.2% | -$538K |
2013 Q2
4 quarters
|
|
84
DELISTED
Praxair Inc
PX
| $225M | 0.25% |
1,693,370
-13,100
| -0.8% | -$1.72M |
2013 Q2
4 quarters
|
|
|
PCYC
85
DELISTED
PHARMACYCLICS INC
PCYC
| $208M | 0.23% |
2,313,039
-67,700
| -3% | -$6.35M |
2013 Q2
4 quarters
|
|
86
Whirlpool
WHR
$1.83B
| $207M | 0.23% |
1,487,050
-24,350
| -2% | -$3.57M |
2013 Q2
4 quarters
|
|
87
Nektar Therapeutics
NKTR
$1.29B
| $203M | 0.22% |
1,053,619
+18,013
| +2% | +$3.19M |
2013 Q2
4 quarters
|
|
|
DWA
88
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $200M | 0.22% |
8,601,200
-59,600
| -0.7% | -$1.56M |
2013 Q2
4 quarters
|
|
|
ITMN
89
DELISTED
INTERMUNE INC
ITMN
| $200M | 0.22% |
4,525,925
-2,101,575
| -32% | -$77.4M |
2013 Q2
4 quarters
|
|
|
90
Jacobs Solutions
J
$16.6B
| $198M | 0.22% |
4,487,490
+1,756,642
| +64% | +$83.6M |
2013 Q2
4 quarters
|
|
91
RB Global
RBA
$16.1B
| $188M | 0.21% |
7,645,452
-76,900
| -1% | -$1.83M |
2013 Q2
4 quarters
|
|
92
Deere & Co
DE
$175B
| $180M | 0.2% |
1,993,000
| – | – |
2013 Q2
4 quarters
|
|
93
Willis Towers Watson
WTW
$28.8B
| $175M | 0.19% |
1,524,855
-29,181
| -2% | -$3.28M |
2013 Q2
4 quarters
|
|
94
Sanofi
SNY
$96.5B
| $160M | 0.18% |
3,011,646
+534,790
| +22% | +$28.4M |
2013 Q2
4 quarters
|
|
95
F5
FFIV
$25.9B
| $160M | 0.17% |
1,431,260
-7,535
| -0.5% | -$811K |
2013 Q2
4 quarters
|
|
96
Applied Materials
AMAT
$341B
| $158M | 0.17% |
6,992,455
-68,968
| -1% | -$1.41M |
2013 Q2
4 quarters
|
|
97
Royal Caribbean
RCL
$74.9B
| $156M | 0.17% |
2,800,301
-217,702
| -7% | -$11.7M |
2013 Q2
4 quarters
|
|
|
ASNA
98
DELISTED
Ascena Retail Group, Inc.
ASNA
| $155M | 0.17% |
453,445
+105,875
| +30% | +$36.2M |
2013 Q2
4 quarters
|
|
99
eBay
EBAY
$54.7B
| $151M | 0.17% |
7,179,084
+1,437,718
| +25% | +$31.3M |
2013 Q3
3 quarters
|
|
100
Comscore
SCOR
$61.2M
| $151M | 0.17% |
212,782
-4,595
| -2% | -$2.96M |
2013 Q2
4 quarters
|
|
Similar funds
Primecap Management's Q2 2014 Portfolio in Review
As of Q2 2014, Primecap Management held 259 positions worth $91.3B, up 3.4% from $88.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4.6%. Primecap Management opened 7 new positions and exited 5, leaving the 259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2014 buy was Exact Sciences: 2,491,300 shares worth $42.4M.
- Primecap Management added most to United Airlines in Q2 2014, an estimated $144M increase.
- Primecap Management's biggest Q2 2014 reduction was GSK, cutting an estimated $218M.
- Primecap Management fully exited Akamai in Q2 2014, selling an estimated $4.77M.
- Primecap Management's ten largest holdings make up 35% of its $91.3B portfolio in Q2 2014.
- Primecap Management opened 7 new positions and closed 5 in Q2 2014.
- Primecap Management's portfolio value rose 3.4% quarter-over-quarter to $91.3B.
Based on Primecap Management's 13F filing for Q2 2014, filed 14 Aug 2014.